News Muncher - searching for ntagi

11 months ago

The importance of periodic testing for Human Papillomavirus

The New Year brings a whole host of resolutions. Now, says Dr. Gajaraj, HPV DNA testing is the recommended method for screening for cervical cancer: this involves testing cells from the cervix for infections with any of the HPV types that could cause cancer. The WHO, too, recommends that HPV DNA testing be the first-choice screening method for cervical cancer …

Health India Cancer Women Girls Screening Cervical

11 months, 1 week ago

Health Ministry yet to take a call on beginning HPV vaccination campaign for adolescent girls

The Hindu

The Health Ministry maintained on Saturday that it is yet to take a decision on starting a vaccination campaign against the human papillomavirus, despite reports that it is set to offer the vaccine from the second quarter of this year. The Ministry had earlier said that in June 2022, after evaluating the fresh evidence on the cervical cancer burden and …

Health India Cancer Vaccination Girls Vaccine Cervical

1 year, 6 months ago

CoWIN data 'leak': Two, including a juvenile, apprehended

India TV News

CoWIN data leak : A man was arrested and a juvenile was apprehended from Bihar in connection with their involvement in the alleged data leak from CoWIN portal, officials said today. There have been claims about a breach of data of citizens registered on the CoWIN platform, and opposition parties have asked the government to take deterrent action. The government …

Data Leak Cowin

1 year, 6 months ago

'CoWIN portal completely safe': Govt refutes claims of data breach

India TV News

The government said that reports of a breach of beneficiaries' data on the CoWIN platform were "mischievous" and "without any basis," and that the matter has been looked at by CERT-In, the country's top cyber security agency. The CoWIN portal is totally protected with sufficient shields for information protection, the Health Ministry said in an explanation, adding an inward activity …

Data Health Ministry Portal Cowin Completely Safe Govt Refutes Claims Refutes Claims

1 year, 10 months ago

Covid-19 | Lurking presence

India Today

On January 23, 2023, India logged just 92 fresh Covid-19 infections and no deaths. China, on the other hand, which is grappling with a major Covid wave triggered by Omicron sub-variant BF.7 and lifting of restrictions, saw record hospitalisations—the highest since the onset of the pandemic, per World Health Organization reports. Since August 2022, a whole bouquet of Omicron sub-variants—BA.2.12.1, …

India Covid

1 year, 10 months ago

India to include vaccine against cervical cancer in immunisation programme

Live Mint

Centre is likely to include HPV vaccine in the national immunisation programme for girls aged nine to 14 years in June, sources close to the government informed adding that a global tender for the same is likely to be floated in April. Apart from domestic manufacturer Serum Institute of India, global vaccine manufacturer Merck is also likely to participate in …

Global India Cancer Vaccine Cervical Hpv Cervical Cancer

1 year, 11 months ago

SII launches first made-in-India HPV vaccine. Details here

Live Mint

Serum Institute India on Tuesday launched the first made-in-India HPV vaccine on the occasion of India's national girl child day and cervical cancer awareness month. Tweeting about the same, Adar Poonawalla, CEO and chairman of the company, said, on the occasion of India's National Girl Child Day and Cervical Cancer Awareness Month, Serum Institute India is pleased to launch the …

Vaccine India Hpv Sii Launches

1 year, 11 months ago

‘Erroneous’: Centre dismisses Covid vaccine's ‘multiple side effects’ report

Hindustan Times

Union ministry of health and family welfare on Tuesday dismissed media reports regarding the Indian Council of Medical Research and Central Drugs Standard Control Organisation admitting to ‘multiple side-effects Covid-19 vaccines'. Terming the report “erroneous”, the ministry said that ICMR has only provided a list of benefits and drawbacks of the Covid-19 vaccine. Read| Centre unlikely to procure more Covid …

India Covid Ministry Vaccine Icmr Side Effects

1 year, 11 months ago

Multiple COVID vaccine side-effects: Health Ministry clears air on recent report

Live Mint

The Union Health Ministry has reiterated that only a small percentage of patients who receive the COVID-19 vaccine may develop serious adverse events depending on certain predisposing circumstances, refuting the reports of various side effects of the vaccine. According to a recent media report, the Central Drugs Standard Control Organization and the Indian Council of Medical Research have acknowledged "multiple …

Health India Vaccines Covid Ministry Vaccine Health Ministry

1 year, 11 months ago

Second COVID-19 booster dose not required, says government sources

Firstpost

New Delhi: Based on the current Covid-19 situation in the country, there is no need to administer a second booster dose, government sources told ANI, as the Union Health Ministry data on Tuesday showed that only 134 new coronavirus cases were recorded throughout the nation in the last 24 hours with the daily positivity rate at 0.09 per cent “As …

Second Booster Dose

2 years ago

Mandaviya's Covid review meet tomorrow as China sees sharp spike in cases

Hindustan Times

With China reporting a sharp rise in Covid-19 cases, Union health minister Mansukh Mandaviya decided to chair a coronavirus review meeting on Wednesday. "ln view of the sudden spurt of cases being witnessed in Japan, the United States of America, Republic of Korea, Brazil and China, it is essential to gear up the whole genome sequencing of positive case samples …

China Covid

2 years ago

India to soon launch HPV vaccines for Cervical Cancer; know about its doses and diagnosis

India TV News

Cervical cancer can be treated with the HPV vaccine and India is soon to take steps in this area. Dr. NK Arora, head of the National Technical Advisory Group on Immunization, said that cervical cancer can be treated with the HPV vaccine. Teens and young adults through age 26 years who didn’t start or finish the HPV vaccine series also …

India Cancer Vaccination Age Vaccine Cervical Hpv

2 years, 4 months ago

COVID-19: Corbevax to be given as boosters at vaccination centres from today

Live Mint

Hyderabad based-Biological E Ltd 's recently approved heterologous Covid-19 vaccine Corbevax to be available as a booster dose on the COWIN App in both public and private vaccination centres from 12 August, the firm said on 11 August. The Union Health Ministry approved Corbevax as India's first heterologous COVID-19 booster shot for 18 years and above after the six months …

India Vaccination Vaccine Booster Emergency Use Corbevax Vaccination Centres

2 years, 4 months ago

Adults may get different vaccine as booster shot instead of Covishield, Covaxin

Live Mint

As the government has continued to emphasize Covid booster doses due to the rising number of cases, a panel has recommended a different vaccine for Indian adults. Government panel National Technical Advisory Group on Immunisation has recommended Biological E's Corbevax as a precaution dose for adults fully vaccinated with either Covishield or Covaxin. "Corbevax may be considered for a third/precaution …

India Covid Vaccine Doses Dose Covaxin Covishield

2 years, 5 months ago

Free COVID-19 booster shots for all adults for 75 days from July 15 at government centres

The Hindu

As part of the Azadi Ka Amrit Mahotsav celebrations, free precaution doses of COVID-19 vaccines will be available for all citizens above 18 years of age at government vaccination centres from July 15 for 75 days, Anurag Singh Thakur, Union Minister of Information and Broadcasting, announced on July 13, following a meeting of the Union Cabinet. India’s cumulative COVID-19 vaccination …

India Vaccination Age Covid 18 Years

2 years, 5 months ago

DCGI Grants Marketing Authorisation to SII's QHPV Vaccine Against Cervical Cancer

News 18

The Drugs Controller General of India on Tuesday granted market authorisation to Serum Institute of India to manufacture indigenously-developed India’s first Quadrivalent Human Papillomavirus vaccine against cervical cancer, official sources said. Prakash Kumar Singh, director at Serum Institute, had applied to the DCGI seeking market authorisation of qHPV after the phase 2/3 clinical trial was completed with support of the …

India Cancer Singh Vaccine Hpv Cervical Cancer Dcgi

2 years, 5 months ago

NTAGI Panel Recommends Use of Covid Vaccines Corbevax, Covaxin for Kids Aged 5-12 Years

News 18

The NTAGI's Standing Technical Sub-Committee approved the use of COVID-19 vaccines Corbevax and Covaxin for children aged between five and 12 years, official sources said on Friday. Data of Biological E's Corbevax and Bharat Biotech's Covaxin for children aged between five and 12 years were reviewed in the STSC meeting held on June 16 and members decided that the vaccines …

Covid 12 Years Corbevax

2 years, 5 months ago

Corbevax, Covaxin vacines get nod for use among 5-12 years olds; details here

Live Mint

Biological E's Corbevax and Bharat Biotech's Covaxin on July 8 received the nod from the National Technical Advisory Group on Immunisation's Standing Technical Sub-Committee for use among children aged between 5-12 years. The Drugs Controller General of India granted emergency use authorisation to the Biological E's Corbevax for 5-12 year old and Bharat Biotech's Covaxin for minors belonging to the …

India Age Group Covovax Corbevax Covaxin

2 years, 5 months ago

Gap between 2nd COVID-19 jab and precaution dose reduced to six months

The Hindu

The Health Ministry, on Wednesday, decided to reduce the gap between the second dose and precaution dose of COVID-19 vaccine to six months for all adults in view of the recommendation by National Technical Advisory Group on Immunization. The Health Ministry in its communication to States said that in view of the evolving scientific evidence and global practices, the Standing …

Covid Months 6 Months Dose Cowin 26 Weeks Precaution Dose

2 years, 5 months ago

Government reduces gap between second COVID-19 dose and booster shot from 9 to 6 months

Firstpost

The decision to reduce the gap between the two doses were taken by the government’s advisory body on vaccination NTAGI New Delhi: The Ministry of Health and Family Welfare on Wednesday, reduced the gap between the second COVID vaccine dose and precautionary dose to six month from the existing nine months. “In view of the evolving scientific evidence and global …

Months 6 Months Dose 26 Weeks Ntagi 2Nd Dose

2 years, 5 months ago

Allowing Corbevax as booster for those vaccinated with Coivishield, Covaxin likely to be considered by NTAGI

The Hindu

Allowing Biological E’s Corbevax as a booster for those fully vaccinated against COVID-19 with either Covishield or Covaxin is likely to be considered by the NTAGI, which is scheduled to meet on Tuesday, sources said. “The National Technical Advisory Group on Immunisation will discuss allowing Corbevax, which has been cleared by the DCGI, as a booster for those fully vaccinated …

India Corbevax Ntagi Allowing

2 years, 6 months ago

Vaccination advisory group recommends reducing COVID-19 booster dose gap to 6 months

The Hindu

The Standing Technical Sub-Committee of the NTAGI on Thursday recommended reducing the gap between the second and precaution doses of COVID-19 vaccines from the current nine to six months, official sources said. The government advisory panel, which met on Thursday, also reviewed the findings of a study by the Christian Medical College in Vellore on the feasibility of allowing as …

Covid Booster Dose

2 years, 6 months ago

NTAGI to Review Covaxin, Corbevax Data for 6-12 Yrs Thursday, Discuss Reducing Booster Dose Gap

News 18

Government advisory panel NTAGI will meet on Thursday to review data on Covaxin and Corbevax vaccines for the 6-12 age group and also deliberate on reducing the gap between the second and precaution doses from the current nine to six months. The agenda for the NTAGI's Standing Technical Sub-Committee meeting includes a discussion on a study by the CMC Vellore …

Months Six Months Dose Corbevax Vaccine Ntagi Review Covaxin

2 years, 6 months ago

Modi@8: India’s Covid Vax Drive is a Myth Breaker in Public Health Space, Writes NTAGI Head NK Arora

News 18

Not so long back, a reputed international media-house had predicted gloomily that it could take over a decade for India to vaccinate its 1.4 billion population against Covid-19. The resounding success of this drive, which has been a proactive, pre-emptive, and graded response in the management of Covid-19 has been a myth-breaker on several fronts in the public health space …

Health India Vaccination Indian Vaccines Public Covid

Filters

Search results for ntagi

The importance of periodic testing for Human Papillomavirus

Health Ministry yet to take a call on beginning HPV vaccination campaign for adolescent girls

CoWIN data 'leak': Two, including a juvenile, apprehended

'CoWIN portal completely safe': Govt refutes claims of data breach

Covid-19 | Lurking presence

India to include vaccine against cervical cancer in immunisation programme

SII launches first made-in-India HPV vaccine. Details here

‘Erroneous’: Centre dismisses Covid vaccine's ‘multiple side effects’ report

Multiple COVID vaccine side-effects: Health Ministry clears air on recent report

Second COVID-19 booster dose not required, says government sources

Mandaviya's Covid review meet tomorrow as China sees sharp spike in cases

India to soon launch HPV vaccines for Cervical Cancer; know about its doses and diagnosis

COVID-19: Corbevax to be given as boosters at vaccination centres from today

Adults may get different vaccine as booster shot instead of Covishield, Covaxin

Free COVID-19 booster shots for all adults for 75 days from July 15 at government centres

DCGI Grants Marketing Authorisation to SII's QHPV Vaccine Against Cervical Cancer

NTAGI Panel Recommends Use of Covid Vaccines Corbevax, Covaxin for Kids Aged 5-12 Years

Corbevax, Covaxin vacines get nod for use among 5-12 years olds; details here

Gap between 2nd COVID-19 jab and precaution dose reduced to six months

Government reduces gap between second COVID-19 dose and booster shot from 9 to 6 months

Allowing Corbevax as booster for those vaccinated with Coivishield, Covaxin likely to be considered by NTAGI

Vaccination advisory group recommends reducing COVID-19 booster dose gap to 6 months

NTAGI to Review Covaxin, Corbevax Data for 6-12 Yrs Thursday, Discuss Reducing Booster Dose Gap

Modi@8: India’s Covid Vax Drive is a Myth Breaker in Public Health Space, Writes NTAGI Head NK Arora